脓毒症相关急性肾损伤机制研究的候选生物标志物
该研究建立小鼠PERSEVERE模型(mPERSEVERE),对8周龄C57BL/6雄性小鼠行盲肠结扎穿孔(CLP)诱导脓毒症,于CLP后8小时采集mPERSEVERE生物标志物、24小时取肾。35只小鼠行CLP,mPERSEVERE判定为死亡高风险的小鼠中70%在24小时发生SA-AKI,低风险小鼠为22%。CART分析识别CCL3与KC两项标志物对SA-AKI预测的受试者工作曲线下面积为0.90;发生SA-AKI的小鼠肾组织KC表达显著升高(p=0.013),CCL3肾表达无差异,KC与CCL3定位于肾小管上皮细胞而非浸润免疫细胞。作者认为需进一步研究KC是否直接参与SA-AKI的病理生物学。
要点
- 35只C57BL/6雄性小鼠行CLP诱导脓毒症,CLP后8小时采集mPERSEVERE标志物、24小时取肾。
- mPERSEVERE判定为死亡高风险的小鼠中70%在24小时发生SA-AKI,低风险小鼠为22%。
- CART分析显示血浆CCL3+KC联合预测SA-AKI的受试者工作曲线下面积为0.90。
- 发生SA-AKI的小鼠肾组织KC表达显著升高(p=0.013),CCL3肾表达在SA-AKI与非SA-AKI小鼠间无差异。
- 免疫组化显示KC与CCL3定位于肾小管上皮细胞,而非浸润免疫细胞。
适用人群与场景
- 8周龄C57BL/6雄性小鼠,经盲肠结扎穿孔(CLP)诱导脓毒症。
研究设计与关键结果
- 研究类型:小鼠脓毒症模型机制研究;35只8周龄C57BL/6雄性小鼠行CLP,CLP后8小时采集mPERSEVERE标志物、24小时取肾。
- mPERSEVERE判定为死亡高风险的小鼠中70%在24小时发生SA-AKI,低风险小鼠为22%。
- CART分析识别CCL3与KC为SA-AKI的最强预测标志物,受试者工作曲线下面积为0.90。
- 发生SA-AKI的小鼠肾组织KC表达较未发生SA-AKI的小鼠显著升高(p=0.013);CCL3肾表达在SA-AKI与非SA-AKI小鼠间无差异。
- 免疫组化显示KC与CCL3定位于肾小管上皮细胞,而非浸润免疫细胞。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP脓毒症模型)。
- 局限:作者指出需进一步研究以确定KC是否直接参与SA-AKI的潜在病理生物学。
对床旁实践的改变
- 作者认为,血浆CCL3+KC联合可在CLP后24小时预测小鼠SA-AKI的发生;需进一步研究确定KC是否直接参与SA-AKI的病理生物学。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Sepsis-associated acute kidney injury (SA-AKI) is a frequent complication of sepsis, yet the pathophysiologic mechanisms of SA-AKI are incompletely understood. PERSEVERE is a clinically validated serum biomarker panel with high sensitivity in predicting mortality from sepsis, and recent evidence suggests it can also predict severe, persistent SA-AKI at day 3 of hospitalization among septic children. We developed a murine model of PERSEVERE (mPERSEVERE) to further interrogate the sepsis-related biological underpinnings of SA-AKI using candidate biomarkers within mPERSEVERE.
METHODS: Eight-week-old C57BL/6 male mice underwent induction of sepsis by cecal ligation and puncture (CLP). mPERSEVERE biomarkers were collected at 8-hours and kidneys were harvested at 24-hours post-CLP Classification and regression tree analysis (CART) was used to generate a SA-AKI predictive model. Kidney gene expression levels of candidate biomarkers were quantified using real time polymerase chain reaction.
RESULTS: Thirty- five mice underwent CLP Among mice identified by mPERSEVERE as high-risk for mortality, 70% developed SA-AKI at 24-hours compared to 22% of low-risk mice. CART analysis identified two mPERSEVERE biomarkers-C-C motif chemokine ligand 3 (CCL3) and keratinocyte-derived chemokine (KC)-as most predictive for SA-AKI with an area under the receiver operating curve of 0.90. In mice that developed SA-AKI, renal expression of KC was significantly increased compared to mice without SA-AKI (p = 0.013), whereas no difference was seen in renal expression of CCL3 in mice with SA-AKI vs. no SA-AKI. KC and CCL3 localized to renal tubule epithelial cells as opposed to infiltrating immune cells by immunohistochemistry.
CONCLUSIONS: The combination of plasma CCL3+KC can predict SA-AKI development in mice at 24-hours following CLP Of these two biomarkers, only renal expression of KC is increased in mice with SA-AKI. Further studies are required to determine if KC directly contributes to the underlying pathobiology of SA-AKI.
参考来源
- Odum JD, Standage S, Alder M, et al. Candidate Biomarkers for Sepsis-Associated Acute Kidney Injury Mechanistic Studies. Shock. 2022. PMID: 35234208. doi:10.1097/SHK.0000000000001916
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。